A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

Rotigotine Effect on All-day Functioning and Quality of Life in Subjects With Moderate to Severe Restless Legs Syndrome (RLS)

NCT01569464 ·Status: COMPLETED ·Phase: PHASE3

Ropinirole Tablets In Young Patients With Restless Legs Syndrome

NCT00140712 ·Status: COMPLETED ·Phase: PHASE1

Restless Legs Patient Study On Absorption, Distribution, Metabolism And Excretion Of Ropinirole And The Effect Of Food

NCT00419692 ·Status: COMPLETED ·Phase: PHASE1

Effect of Ropinirole on Spinal Cord Reflexes and Restless Legs Syndrome

NCT00051961 ·Status: COMPLETED

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

NCT00530790 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of Cabergoline Compared With Placebo for the Treatment of RLS

NCT00627003 ·Status: COMPLETED ·Phase: PHASE3

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole

NCT00344994 ·Status: COMPLETED ·Phase: PHASE4

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

NCT00806026 ·Status: COMPLETED ·Phase: PHASE3

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

NCT00152958 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Rasagiline in Restless Legs Syndrome

NCT01192503 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Bupropion and Restless Legs Syndrome

NCT00621517 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Treatment of Restless Legs Syndrome With the Hypocretin Antagonist Suvorexant

NCT03755310 ·Status: UNKNOWN ·Phase: PHASE2

Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome

NCT00135993 ·Status: COMPLETED ·Phase: PHASE3

Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)

NCT00996944 ·Status: TERMINATED ·Phase: PHASE2

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

NCT02025608 ·Status: COMPLETED ·Phase: PHASE4

Switching From Oral Dopamine Agonists to Rotigotine

NCT01976871 ·Status: COMPLETED ·Phase: PHASE4

Rotigotine Restless Legs Syndrome Dose Finding Trial

NCT00243217 ·Status: COMPLETED ·Phase: PHASE2

Effects of Neupro on Cardiovascular Observations in Patients With Restless Legs Syndrome

NCT01455012 ·Status: COMPLETED ·Phase: PHASE4

Clinical Trial Assessing the Efficacy and Safety of BP1.4979 in Restless Legs Syndrome

NCT03345953 ·Status: TERMINATED ·Phase: PHASE2

Three Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Leg Syndrome

NCT00136045 ·Status: COMPLETED ·Phase: PHASE3

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

NCT00895232 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Safety and Tolerability of Rotigotine Nasal Spray for the Acute Treatment of RLS Symptoms

NCT00389831 ·Status: COMPLETED ·Phase: PHASE2

A Study of Rotigotine Patch in Adolescent Subjects With Restless Legs Syndrome of Unknown Cause

NCT03728933 ·Status: TERMINATED ·Phase: PHASE3

Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist

NCT03218969 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Lyrica Dose Response Study With Restless Legs Syndrome (RLS) Patients

NCT00676403 ·Status: COMPLETED ·Phase: PHASE2